Smoking Cessation And Stigma With Jamie Ostroff Matthew Steliga And Jim Pantelas
Providing smoking cessation without contributing to the stigma faced by those who smoke is a worthwhile goal. To discuss this in greater detail, Lung Cancer Considered host Dr. Narjust Duma welcomes D...
17 Mai 202243min
Lung Cancer Screening With Hilary Robbins And Brendon Stiles
Dr. Hilary Robbins, an epidemiologist with the International Agency for Research on Cancer, and Dr. Brendon Stiles, chief of Thoracic Surgery and Surgical Oncology at Montefiore-Einstein Cancer Center...
3 Mai 202238min
Climate Change and Lung Cancer With Joan Schiller and Eric Bernicker
On a special Earth Day episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by two vocal IASLC members who have taken a passionate interest in understanding more about the climate crisis ...
22 Apr 202248min
Lung Cancer Considered 100th Episode - Interview with new IASLC CEO, Dr. Karen Kelly
In the 100th episode of IASLC's Lung Cancer Considered, host Dr. Narjust Duma interviews new IASLC CEO, Dr. Karen Kelly. Dr. Kelly is recognized internationally for her expertise in lung cancer resea...
19 Apr 202238min
ELCC 2022 Highlights With Nicolas Girard And Lizza Hendriks
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recently completed European Lung Cancer Congress. His guests include Dr. Lizza Hendriks, assistant professor at Maastric...
5 Apr 202226min
Breakthrough Therapies NTRK With Robert Doebele
In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent ...
15 Mar 202232min
Targeted Therapies of Lung Cancer with Charu Aggarwal Lecia Sequist and Ivy Elkins
The IASLC Targeted Therapies Meeting has historically been a very interactive, fast-paced meeting that highlights the latest and most innovative anticancer drugs, initially focused on targeted agents ...
1 Mar 202248min
NTRK with Herbert Ho Fung Loong
Neurotrophic tyrosine receptor kinase fusion, or NTRK, has emerged in the last six years as a rare, but targetable alteration in several cancers. Dr. Herbert Loong, clinical assistant professor in the...
22 Feb 202226min
